1
|
Sam-Yellowe TY. Nutritional Barriers to the Adherence to the Mediterranean Diet in Non-Mediterranean Populations. Foods 2024; 13:1750. [PMID: 38890978 PMCID: PMC11171913 DOI: 10.3390/foods13111750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2024] [Revised: 05/16/2024] [Accepted: 05/29/2024] [Indexed: 06/20/2024] Open
Abstract
Adherence to the Mediterranean diet has been shown to lower the risk of developing chronic non-communicable diseases like cardiovascular and neurodegenerative diseases and cancer. Improvements in depression, participation in daily activities in older individuals, weight loss and a reduction in adverse pregnancy outcomes are associated with adherence to the Mediterranean diet. The number of studies that have evaluated barriers to adherence to the Mediterranean diet in the US and, in particular, in racial and ethnic minority populations within the US are few. Among Native American and Alaskan Native populations, studies evaluating traditional or alternative Mediterranean diet adherence for chronic non-infectious diseases is unavailable. Mediterranean diet scoring instruments used in studies in European and Mediterranean countries and among white participants in the US fail to capture the dietary patterns of racial and ethnic minority populations. In this narrative review, the food components of the traditional Mediterranean diet are discussed, adherence to the Mediterranean diet is examined in Mediterranean and non-Mediterranean countries and barriers preventing adherence to the Mediterranean diet in the US and among racial and ethnic minority populations is reviewed. Recommendations for improving nutrition education and intervention and for increasing adherence and cultural adaptions to the Mediterranean diet are provided.
Collapse
Affiliation(s)
- Tobili Y. Sam-Yellowe
- Graduate College, Canisius University, 2001 Main Street, Buffalo, NY 14208-1098, USA;
- Department of Biological, Geological and Environmental Sciences, Cleveland State University, 2121 Euclid Avenue, Cleveland, OH 44115, USA
| |
Collapse
|
2
|
Mazzucca CB, Scotti L, Raineri D, Cappellano G, Chiocchetti A. Design and Validation of MEDOC, a Tool to Assess the Combined Adherence to Mediterranean and Western Dietary Patterns. Nutrients 2024; 16:1745. [PMID: 38892678 PMCID: PMC11175000 DOI: 10.3390/nu16111745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2024] [Revised: 05/29/2024] [Accepted: 05/31/2024] [Indexed: 06/21/2024] Open
Abstract
The Mediterranean diet (MD) and Western diet (WD) are poles apart as dietary patterns. Despite the availability of epidemiological tools to estimate the adherence to MD, to date, there is a lack of combined scores. We developed MEDOC, a food frequency questionnaire (FFQ) designed to calculate a combined adherence score for both diets and validated it on 213 subjects. The test-retest reliability revealed all frequency questions falling within the acceptable range of 0.5 to 0.7 (Pearson correlation coefficient) in younger (<30 years old) subjects, while 1 question out of 39 fell below the range in older (>30 years old) participants. The reproducibility for portion size was less satisfying, with, respectively, 38.2% and 70.5% of questions falling below 0.5 (Cohen's Kappa index) for younger and older subjects. The good correlation (R = 0.63, p < 0.0001 for subjects younger than 30 years and R = 0.54, p < 0.0001 for subjects older than 30 years, Pearson's correlation coefficient) between the MEDOC score and the MediDietScore (MDS) confirmed the validity of the MEDOC score in identifying patients who adhere to the MD. Harnessing the capabilities of this innovative tool, we aim to broaden the existing perspective to study complex dietary patterns in nutritional epidemiology studies.
Collapse
Affiliation(s)
- Camilla Barbero Mazzucca
- Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases—IRCAD, University of Eastern Piedmont, 28100 Novara, Italy; (C.B.M.); (D.R.); (G.C.)
- Center for Translational Research on Autoimmune and Allergic Disease—CAAD, Università del Piemonte Orientale, 28100 Novara, Italy
| | - Lorenza Scotti
- Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy;
| | - Davide Raineri
- Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases—IRCAD, University of Eastern Piedmont, 28100 Novara, Italy; (C.B.M.); (D.R.); (G.C.)
- Center for Translational Research on Autoimmune and Allergic Disease—CAAD, Università del Piemonte Orientale, 28100 Novara, Italy
| | - Giuseppe Cappellano
- Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases—IRCAD, University of Eastern Piedmont, 28100 Novara, Italy; (C.B.M.); (D.R.); (G.C.)
- Center for Translational Research on Autoimmune and Allergic Disease—CAAD, Università del Piemonte Orientale, 28100 Novara, Italy
| | - Annalisa Chiocchetti
- Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases—IRCAD, University of Eastern Piedmont, 28100 Novara, Italy; (C.B.M.); (D.R.); (G.C.)
- Center for Translational Research on Autoimmune and Allergic Disease—CAAD, Università del Piemonte Orientale, 28100 Novara, Italy
| |
Collapse
|
3
|
Alesi S, Villani A, Mantzioris E, Takele WW, Cowan S, Moran LJ, Mousa A. Anti-Inflammatory Diets in Fertility: An Evidence Review. Nutrients 2022; 14:nu14193914. [PMID: 36235567 PMCID: PMC9570802 DOI: 10.3390/nu14193914] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Revised: 09/16/2022] [Accepted: 09/18/2022] [Indexed: 11/16/2022] Open
Abstract
Infertility is a global health concern affecting 48 million couples and 186 million individuals worldwide. Infertility creates a significant economic and social burden for couples who wish to conceive and has been associated with suboptimal lifestyle factors, including poor diet and physical inactivity. Modifying preconception nutrition to better adhere with Food-Based Dietary Guidelines (FBDGs) is a non-invasive and potentially effective means for improving fertility outcomes. While several dietary patterns have been associated with fertility outcomes, the mechanistic links between diet and infertility remain unclear. A key mechanism outlined in the literature relates to the adverse effects of inflammation on fertility, potentially contributing to irregular menstrual cyclicity, implantation failure, and other negative reproductive sequelae. Therefore, dietary interventions which act to reduce inflammation may improve fertility outcomes. This review consistently shows that adherence to anti-inflammatory diets such as the Mediterranean diet (specifically, increased intake of monounsaturated and n-3 polyunsaturated fatty acids, flavonoids, and reduced intake of red and processed meat) improves fertility, assisted reproductive technology (ART) success, and sperm quality in men. Therefore, integration of anti-inflammatory dietary patterns as low-risk adjunctive fertility treatments may improve fertility partially or fully and reduce the need for prolonged or intensive pharmacological or surgical interventions.
Collapse
Affiliation(s)
- Simon Alesi
- Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3168, Australia
| | - Anthony Villani
- School of Health and Behavioural Sciences, University of the Sunshine Coast, Sippy Downs, QLD 4556, Australia
| | - Evangeline Mantzioris
- Clinical and Health Sciences & Alliance for Research in Nutrition, Exercise and Activity (ARENA), University of South Australia, Adelaide, SA 5001, Australia
| | - Wubet Worku Takele
- Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3168, Australia
| | - Stephanie Cowan
- Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3168, Australia
| | - Lisa J. Moran
- Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3168, Australia
| | - Aya Mousa
- Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3168, Australia
- Correspondence: ; Fax: +61-3-9594-7554
| |
Collapse
|
4
|
Woodside J, Young IS, McKinley MC. Culturally adapting the Mediterranean Diet pattern - a way of promoting more 'sustainable' dietary change? Br J Nutr 2022; 128:693-703. [PMID: 35734884 PMCID: PMC9346614 DOI: 10.1017/s0007114522001945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Average diet quality is low in the UK and is socioeconomically patterned, contributing to the risk of non-communicable disease and poor health. Achieving meaningful dietary change in the long term is challenging, with intervention required on a number of different levels which reflect the multiple determinants of dietary choice. Dietary patterns have been identified which contribute positively to health outcomes; one of these is the Mediterranean diet (MD) which has been demonstrated to be associated with reduced non-communicable disease risk. Most research exploring the health benefits of the MD has been conducted in Mediterranean regions but, increasingly, research is also being conducted in non-Mediterranean regions. The MD is a dietary pattern that could have positive impacts on both health and environmental outcomes, while being palatable, appetising and acceptable. In this review, we consider the studies that have explored transferability of the MD. To achieve long-term dietary change towards a MD, it is likely that the dietary pattern will have to be culturally adapted, yet preserving the core health-promoting elements and nutritional composition, while considering the food system transition required to support changes at population level. Population-specific barriers need to be identified and ways sought to overcome these barriers, for example, key food availability and cost. This should follow a formal cultural adaptation framework. Such an approach is likely to enhance the extent of adherence in the longer term, thus having an impact on population health.
Collapse
Affiliation(s)
- Jayne Woodside
- Centre for Public Health, Institute for Clinical Science A, Grosvenor Road, Belfast, Queen’s University Belfast, BelfastBT12 6BJ, UK
- Institute for Global Food Security, Queen’s University Belfast, Belfast, UK
- Corresponding author: Jayne Woodside, email
| | - Ian S. Young
- Centre for Public Health, Institute for Clinical Science A, Grosvenor Road, Belfast, Queen’s University Belfast, BelfastBT12 6BJ, UK
- Institute for Global Food Security, Queen’s University Belfast, Belfast, UK
| | - Michelle C. McKinley
- Centre for Public Health, Institute for Clinical Science A, Grosvenor Road, Belfast, Queen’s University Belfast, BelfastBT12 6BJ, UK
- Institute for Global Food Security, Queen’s University Belfast, Belfast, UK
| |
Collapse
|
5
|
Increased Adherence to the Mediterranean Diet after Lifestyle Intervention Improves Oxidative and Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease. Antioxidants (Basel) 2022; 11:antiox11081440. [PMID: 35892642 PMCID: PMC9332159 DOI: 10.3390/antiox11081440] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2022] [Revised: 07/13/2022] [Accepted: 07/20/2022] [Indexed: 11/30/2022] Open
Abstract
Background: A Mediterranean diet (MedDiet) is recommended as a therapy for non-alcoholic fatty liver disease (NAFLD) because there is no specific pharmacological treatment for this disease. Objective: To assess the relationship between the adherence to the Mediterranean diet and the intrahepatic fat content (IFC), levels of oxidative stress, and inflammation biomarkers after a 6-month lifestyle intervention in NAFLD patients. Methods: Patients diagnosed with NAFLD (n = 60 adults; 40–60 years old) living in the Balearic Islands, Spain, were classified into two groups, according to the adherence to the MedDiet after 6 months of lifestyle intervention. Anthropometry, blood pressure, IFC, maximal oxygen uptake, and pro/antioxidant and inflammatory biomarkers were measured in plasma and in PBMCs before and after the intervention. Results: Reductions in weight, body mass index, IFC, blood pressure levels, circulating glucose, glycosylated hemoglobin, and markers of liver damage—aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), and cytokeratin 18 (CK-18)—were observed after the intervention. The highest reductions were observed in the group with the best adherence to the MedDiet. A significant improvement in cardiorespiratory fitness was also observed in the group with a higher adherence. The activities of catalase in plasma and catalase and superoxide dismutase in blood mononuclear cells increased only in the group with a higher adherence, as well as the catalase gene expression in the blood mononuclear cells. The plasma levels of malondialdehyde and myeloperoxidase decreased, and resolvin-D1 increased in both groups after the intervention, whereas interleukin-6 levels decreased only in the group with a higher adherence to the MedDiet. Conclusions: A greater adherence to the MedDiet is related to greater improvements in IFC, cardiorespiratory fitness, and pro-oxidative and proinflammatory status in NAFLD patients after a 6-month nutritional intervention based on the MedDiet.
Collapse
|
6
|
Ketogenic and Modified Mediterranean Diet as a Tool to Counteract Neuroinflammation in Multiple Sclerosis: Nutritional Suggestions. Nutrients 2022; 14:nu14122384. [PMID: 35745113 PMCID: PMC9229939 DOI: 10.3390/nu14122384] [Citation(s) in RCA: 21] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Revised: 05/26/2022] [Accepted: 05/30/2022] [Indexed: 12/13/2022] Open
Abstract
Ketogenic Diet is a nutritional pattern often used as dietotherapy in inflammatory diseases, including neurological disorders. Applied on epileptic children since 1920, in recent years it has been taken into account again as a tool to both reduce inflammatory burdens and ameliorate the nutritional status of patients affected by different pathologies. Multiple sclerosis (MS) is considered an immune-mediated neuro-inflammatory disease and diet is a possible factor in its pathogenesis. The aim of this work is to investigate the main potential targets of MS-related impairments, in particular the cognitive deficits, focusing on the alteration of biomarkers such as the Brain Derived-Neurotrophic Factor and the Tryptophan/Kynurenine ratio that could play a role on neuroprotection and thus on MS progression. Furthermore, we here propose nutritional suggestions which are useful in the development of a ketogenic diet protocol that takes advantage of the anti-inflammatory properties of low-carbohydrate foods from the Mediterranean diet to be applied to subjects with MS. In conclusion, this approach will allow one to develop the ketogenic diet combined with a modified Mediterranean diet as a possible tool to improve neuroinflammation in multiple sclerosis.
Collapse
|
7
|
Efficacy, Feasibility and Acceptability of a Mediterranean Diet Intervention on Hormonal, Metabolic and Anthropometric Measures in Overweight and Obese Women with Polycystic Ovary Syndrome: Study Protocol. Metabolites 2022; 12:metabo12040311. [PMID: 35448498 PMCID: PMC9029422 DOI: 10.3390/metabo12040311] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Accepted: 03/30/2022] [Indexed: 02/05/2023] Open
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine condition in reproductive-aged women associated with metabolic, reproductive and psychological features. Lifestyle modification (diet/physical activity) is considered first-line treatment for PCOS. However, there is limited high-quality evidence to support therapeutic dietary interventions for PCOS beyond general population-based healthy eating guidelines. Adherence to a Mediterranean diet (MedDiet), with or without energy restriction, improves cardiometabolic health in populations including persons with or at high risk of cardiovascular disease and type 2 diabetes. However, there is limited research examining the MedDiet in PCOS. Therefore, this 12 week randomized controlled trial will investigate the efficacy of a MedDiet on cardiometabolic and hormonal parameters and explore its acceptability and feasibility in PCOS. Forty-two overweight and obese women with PCOS (aged 18–45 years) will be randomized to receive dietary advice consistent with Australian Dietary Guidelines or an ad libitum MedDiet intervention. All participants will receive fortnightly counselling to facilitate behaviour change. The primary outcomes will be changes in insulin resistance, glucose, total testosterone and sex hormone-binding globulin. Secondary outcomes include changes in body weight and feasibility and acceptability of the MedDiet intervention. The results of this study will provide further evidence on specific dietary approaches for management of PCOS.
Collapse
|
8
|
Mantzioris E, Muhlhausler BS, Villani A. Impact of the Mediterranean Dietary pattern on n-3 fatty acid tissue levels-A systematic review. Prostaglandins Leukot Essent Fatty Acids 2022; 176:102387. [PMID: 34929617 DOI: 10.1016/j.plefa.2021.102387] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/22/2021] [Revised: 12/06/2021] [Accepted: 12/10/2021] [Indexed: 02/03/2023]
Abstract
INTRODUCTION The Mediterranean Diet (MedDiet) is described as a plant-based dietary pattern with adherence associated with reductions in chronic disease risk and longevity. Although the nutrient profile is diverse and complex, the MedDiet is often described as a rich source of n-3 polyunsaturated fatty acids (PUFA) derived from fish, seafood and nuts. However, whether MedDiet adherence results in appreciable increases in tissue levels of n-3 PUFAs is yet to be systematically investigated. This systematic review synthesized the literature to determine the impact of the MedDiet on n-3 PUFA tissue levels. MATERIALS AND METHODS Medline, Embase, Amed, and CINAHL databases were searched for studies reporting on adherence to a MedDiet and tissue levels of n-3 PUFAs. PROSPERO registration number is CRD 42020162114. RESULTS Twenty-two studies were included. Seven were observational studies and 15 were randomised controlled trials (RCTs). All observational studies reported a positive relationship between adherence and higher tissue n-3 PUFA levels. Two-thirds (10/15) of RCTs reported significant increases in n-3 PUFA concentrations. DISCUSSION MedDiet adherence is associated with higher tissue levels of n-3 PUFA. However, we report heterogeneity in the description across all MedDiet interventions.
Collapse
Affiliation(s)
- Evangeline Mantzioris
- UniSA: Clinical & Health Sciences, Alliance for Research in Nutrition, Exercise and Activity (ARENA), University of South Australia, North Terrace and Frome Rd, Adelaide SA 5000, Australia.
| | | | - Anthony Villani
- School of Health and Behavioural Sciences, University of the Sunshine Coast, Queensland, Australia
| |
Collapse
|
9
|
Buja A, Grotto G, Zampieri C, Mafrici SF, Cozzolino C, Baldovin T, Brocadello F, Baldo V. Is adherence to the Mediterranean diet associated with good sleep duration in primary-school children? Front Pediatr 2022; 10:959643. [PMID: 36389385 PMCID: PMC9663913 DOI: 10.3389/fped.2022.959643] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Accepted: 10/05/2022] [Indexed: 12/04/2022] Open
Abstract
OBJECTIVE The Mediterranean diet (MD) contributes to preventing numerous chronic diseases and has benefits on cognitive development. Adherence to the MD is associated with sleep quality and duration in adults and adolescents, but this association seems to have been little investigated in primary-school children. The aim of this cross-sectional study was to verify whether good sleep duration was associated with adherence to the MD. DESIGN The study enrolled a sample of Italian primary school children. Their mothers were asked to answer an anonymous, self-administered questionnaire investigating the children's adherence to the MD (using the KidMed score) and variables related to their lifestyles, behavioral traits and socio-economic factors. Logistic regression models were developed to analyze the association between adherence to the MD, entered as the dependent variable, and adequacy of sleep duration. SETTING Primary schools in Padova, Italy. SUBJECTS 267 Italian 6-year-olds in their first year of primary school. RESULTS The multivariate analysis showed an association between adherence to the MD and hours of sleep: for children with a good sleep duration, the odds ratio of a poor-to-moderate adherence to the MD was 0.282 (95% CI, 0.109-0.681, p < 0.05). CONCLUSION Ensuring an adequate sleep duration may be an important strategy for enhancing adherence to the MD. Sleep and dietary education should be included in future health promotion programs.
Collapse
Affiliation(s)
- Alessandra Buja
- Department of Cardiological, Thoracic and Vascular Sciences, and Public Health, University of Padova, Padova, Italy
| | - Giulia Grotto
- Department of Cardiological, Thoracic and Vascular Sciences, and Public Health, University of Padova, Padova, Italy
| | - Chiara Zampieri
- Department of Cardiological, Thoracic and Vascular Sciences, and Public Health, University of Padova, Padova, Italy
| | - Simona Fortunata Mafrici
- Department of Cardiological, Thoracic and Vascular Sciences, and Public Health, University of Padova, Padova, Italy
| | - Claudia Cozzolino
- Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy
| | - Tatjana Baldovin
- Department of Cardiological, Thoracic and Vascular Sciences, and Public Health, University of Padova, Padova, Italy
| | | | - Vincenzo Baldo
- Department of Cardiological, Thoracic and Vascular Sciences, and Public Health, University of Padova, Padova, Italy
| |
Collapse
|
10
|
Association of Adherence to a Mediterranean Diet with Excess Body Mass, Muscle Strength and Physical Performance in Overweight or Obese Adults with or without Type 2 Diabetes: Two Cross-Sectional Studies. Healthcare (Basel) 2021; 9:healthcare9101255. [PMID: 34682935 PMCID: PMC8535373 DOI: 10.3390/healthcare9101255] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2021] [Revised: 09/21/2021] [Accepted: 09/21/2021] [Indexed: 12/17/2022] Open
Abstract
Overweight and obesity in older adults is associated with disability and is exacerbated by the presence of type 2 diabetes (T2DM). There is emerging evidence that adherence to a Mediterranean diet (MedDiet) reduces adiposity and attenuates physical disability. These cross-sectional studies explored the associations of adherence to a MedDiet with body mass index (BMI), adiposity, muscle strength, and physical performance in older adults without diabetes and in middle-aged or older adults with T2DM. MedDiet adherence was assessed using the Mediterranean Diet Adherence Screener. Fat mass and percent body fat were assessed by dual energy X-ray absorptiometry. Muscle strength was assessed using hand-grip strength, while physical performance was assessed using the Short Physical Performance Battery and gait speed. A total of n = 87 participants with T2DM (T2DM sample: 71.2 ± 8.2 years, BMI: 29.5 ± 5.9) and n = 65 participants without diabetes (non-T2DM sample: 68.7 ± 5.6 years, BMI: 33.7 ± 4.9) were included in these analyses. In the T2DM sample, when controlled for age, gender, and appendicular lean mass index, adherence to a MedDiet was inversely associated with BMI, fat mass, and percent body fat. However, this was no longer maintained in the fully adjusted models. Although, adherence to a MedDiet was positively associated with gait speed (β = 0.155; p = 0.050) independent of all covariates used. Adherence to a MedDiet may be a suitable dietary strategy for preserving lower body physical function in middle-aged and older adults with T2DM. However, these findings should be further investigated using well-designed randomised controlled trials and prospective cohort studies with a wider range of adherence scores to investigate temporal associations.
Collapse
|
11
|
Does a MediDiet with additional extra virgin olive oil (EVOO) and pistachios reduce the incidence of gestational diabetes? Endocr Pract 2021; 28:135-141. [PMID: 34481972 DOI: 10.1016/j.eprac.2021.08.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/22/2021] [Revised: 08/05/2021] [Accepted: 08/25/2021] [Indexed: 11/22/2022]
Abstract
OBJECTIVE The present study aimed to evaluate gestational diabetes mellitus (GDM) incidence in pregnant women following the Mediterranean diet with additional extra virgin olive oil (EVOO) and pistachios. METHODS 560 pregnant patients were enrolled in the present study. The Mediterranean diet (MedDiet) was introduced in both the interventional group (IG) and control group (CG). The females received 40 ml of extra virgin olive oil (EVOO) every day along with 25 - 30 gm of roasted pistachios in the interventional group. The incidence of Gestational Diabetes Mellitus (GDM) was recorded along with specific maternal and neonatal outcomes. MATERIALS AND METHODS The nutritional and MEDAS scores were not statistically different among the groups at baseline, but the difference was statistically significant and higher in IG at 24-28 weeks (p = 0.001) and 36-38 weeks (p = 0.001). GDM was diagnosed in 51(20.4%) females in the Control group and 34 (13.6%) females in the Interventional group. The MedDiet significantly reduced the GDM incidence (p=0.02) after adjusting the confounding factors. CONCLUSION The present study depicts that dietary intervention in pregnant women, including MedDiet and increased consumption of EVOO and pistachios, decreased the incidence of GDM.
Collapse
|
12
|
Malavolti M, Naska A, Fairweather-Tait SJ, Malagoli C, Vescovi L, Marchesi C, Vinceti M, Filippini T. Sodium and Potassium Content of Foods Consumed in an Italian Population and the Impact of Adherence to a Mediterranean Diet on Their Intake. Nutrients 2021; 13:nu13082681. [PMID: 34444841 PMCID: PMC8401684 DOI: 10.3390/nu13082681] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2021] [Revised: 07/20/2021] [Accepted: 07/30/2021] [Indexed: 12/25/2022] Open
Abstract
High sodium and low potassium intakes are associated with increased levels of blood pressure and risk of cardiovascular diseases. Assessment of habitual dietary habits are helpful to evaluate their intake and adherence to healthy dietary recommendations. In this study, we determined sodium and potassium food-specific content and intake in a Northern Italy community, focusing on the role and contribution of adherence to Mediterranean diet patterns. We collected a total of 908 food samples and measured sodium and potassium content using inductively coupled plasma mass spectrometry. Using a validated semi-quantitative food frequency questionnaire, we assessed habitual dietary intake of 719 adult individuals of the Emilia-Romagna region. We then estimated sodium and potassium daily intake for each food based on their relative contribution to the overall diet, and their link to Mediterranean diet patterns. The estimated mean sodium intake was 2.15 g/day, while potassium mean intake was 3.37 g/day. The foods contributing most to sodium intake were cereals (33.2%), meat products (24.5%, especially processed meat), and dairy products (13.6%), and for potassium they were meat (17.1%, especially red and white meat), fresh fruits (15.7%), and vegetables (15.1%). Adherence to a Mediterranean diet had little influence on sodium intake, whereas potassium intake was greatly increased in subjects with higher scores, resulting in a lower sodium/potassium ratio. Although we may have underestimated dietary sodium intake by not including discretionary salt use and there may be some degree of exposure misclassification as a result of changes in food sodium content and dietary habits over time, our study provides an overview of the contribution of a wide range of foods to the sodium and potassium intake in a Northern Italy community and of the impact of a Mediterranean diet on intake. The mean sodium intake was above the dietary recommendations for adults of 1.5–2 g/day, whilst potassium intake was only slightly lower than the recommended 3.5 g/day. Our findings suggest that higher adherence to Mediterranean diet patterns has limited effect on restricting sodium intake, but may facilitate a higher potassium intake, thereby aiding the achievement of healthy dietary recommendations.
Collapse
Affiliation(s)
- Marcella Malavolti
- Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy; (M.M.); (C.M.); (L.V.); (T.F.)
| | - Androniki Naska
- Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Mikras Asias 75, 11527 Athens, Greece;
| | - Susan J. Fairweather-Tait
- Norwich Medical School, University of East Anglia, Norwich Research Park, James Watson Road, Norwich NR4 7UQ, UK;
| | - Carlotta Malagoli
- Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy; (M.M.); (C.M.); (L.V.); (T.F.)
| | - Luciano Vescovi
- Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy; (M.M.); (C.M.); (L.V.); (T.F.)
| | - Cristina Marchesi
- Head Office, Direzione Generale, Azienda USL-IRCCS di Reggio Emilia, Via Amendola 2, 42122 Reggio Emilia, Italy;
| | - Marco Vinceti
- Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy; (M.M.); (C.M.); (L.V.); (T.F.)
- Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA
- Correspondence:
| | - Tommaso Filippini
- Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy; (M.M.); (C.M.); (L.V.); (T.F.)
| |
Collapse
|
13
|
Lewgood J, Oliveira B, Korzepa M, Forbes SC, Little JP, Breen L, Bailie R, Candow DG. Efficacy of Dietary and Supplementation Interventions for Individuals with Type 2 Diabetes. Nutrients 2021; 13:2378. [PMID: 34371888 PMCID: PMC8308746 DOI: 10.3390/nu13072378] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2021] [Revised: 07/07/2021] [Accepted: 07/08/2021] [Indexed: 02/06/2023] Open
Abstract
The prevalence of Type 2 diabetes (T2D) is increasing, which creates a large economic burden. Diet is a critical factor in the treatment and management of T2D; however, there are a large number of dietary approaches and a general lack of consensus regarding the efficacy of each. Therefore, the purpose of this narrative review is twofold: (1) to critically evaluate the effects of various dietary strategies on diabetes management and treatment, such as Mediterranean diet, plant-based diet, low-calorie and very low-calorie diets, intermittent fasting, low-carbohydrate and very low-carbohydrate diets, and low glycemic diets and (2) to examine several purported supplements, such as protein, branched-chain amino acids, creatine, and vitamin D to improve glucose control and body composition. This review can serve as a resource for those wanting to evaluate the evidence supporting the various dietary strategies and supplements that may help manage T2D.
Collapse
Affiliation(s)
- Jessica Lewgood
- Faculty of Kinesiology and Health Studies, University of Regina, Regina, SK S4S0A2, Canada; (J.L.); (R.B.)
| | - Barbara Oliveira
- Okanagan Campus, School of Health and Exercise Sciences, University of British Columbia, Kelowna, BC V1V1V7, Canada; (B.O.); (J.P.L.)
| | - Marie Korzepa
- School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; (M.K.); (L.B.)
| | - Scott C. Forbes
- Department of Physical Education Studies, Faculty of Education, Brandon University, Brandon, MB R7A6A9, Canada;
| | - Jonathan P. Little
- Okanagan Campus, School of Health and Exercise Sciences, University of British Columbia, Kelowna, BC V1V1V7, Canada; (B.O.); (J.P.L.)
| | - Leigh Breen
- School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; (M.K.); (L.B.)
| | - Robert Bailie
- Faculty of Kinesiology and Health Studies, University of Regina, Regina, SK S4S0A2, Canada; (J.L.); (R.B.)
| | - Darren G. Candow
- Faculty of Kinesiology and Health Studies, University of Regina, Regina, SK S4S0A2, Canada; (J.L.); (R.B.)
| |
Collapse
|
14
|
Entwistle TR, Miura K, Keevil BG, Morris J, Yonan N, Pohl M, Green AC, Fildes JE. Modifying dietary patterns in cardiothoracic transplant patients to reduce cardiovascular risk: The AMEND-IT Trial. Clin Transplant 2020; 35:e14186. [PMID: 33314283 DOI: 10.1111/ctr.14186] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Revised: 11/29/2020] [Accepted: 12/04/2020] [Indexed: 11/28/2022]
Abstract
BACKGROUND Cardiovascular disease (CVD) is common after cardiothoracic transplantation and causes substantial morbidity. AIMS To assess feasibility and potential effectiveness of dietary interventions to reduce CVD risk. MATERIALS AND METHODS In a pilot intervention, we recruited patients from a tertiary hospital and randomly allocated them to a Mediterranean or low-fat diet for 12 months. Feasibility was measured by patient participation, retention, and adherence. Changes in weight, body mass index (BMI), heart rate, blood pressure, glucose markers, and blood lipids were assessed using longitudinal generalized estimating equation regression models with 95% confidence intervals. RESULTS Of 56 heart and 60 lung transplant recipients, 52 (45%) consented, 41 were randomized, and 39 (95%) completed the study with good adherence to randomized diets. After 12 months, changes in many risk factors were seen in the Mediterranean and low-fat-diet groups, respectively, including mean BMI (-0.5 vs. 0.0 kg/m2 ), systolic/diastolic blood pressure +0.5/+0.1 vs -4.4/-3.5 mmHg; fasting glucose -0.26 vs -0.27 mmol/L; total cholesterol -0.56 vs -0.40 mmol/L. Changes in BMI and systolic/diastolic blood pressure in 49 eligible patients who did not take part were +0.7 kg/m2 and +2.5/+1.8 mmHg. DISCUSSION Dietary interventions in cardiothoracic transplant patients are feasible and potentially beneficial. CONCLUSION A definitive nutritional intervention study in these high-risk patients is warranted.
Collapse
Affiliation(s)
- Timothy R Entwistle
- The Ex-Vivo Lab, Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.,The Transplant Centre, Manchester Foundation Trust, Manchester, UK
| | - Kyoko Miura
- Cancer and Population Studies, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
| | - Brian G Keevil
- Department of Clinical Biochemistry, University Hospital South Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
| | - Julie Morris
- Department of Medical Statistics, Manchester Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
| | - Nizar Yonan
- The Ex-Vivo Lab, Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
| | | | - Adele C Green
- Cancer and Population Studies, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.,CRUK Manchester Institute and University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - James E Fildes
- The Ex-Vivo Lab, Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.,The Transplant Centre, Manchester Foundation Trust, Manchester, UK
| |
Collapse
|
15
|
Understanding the Self-Perceived Barriers and Enablers toward Adopting a Mediterranean Diet in Australia: An Application of the Theory of Planned Behaviour Framework. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2020; 17:ijerph17249321. [PMID: 33322111 PMCID: PMC7764290 DOI: 10.3390/ijerph17249321] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/12/2020] [Revised: 11/26/2020] [Accepted: 12/11/2020] [Indexed: 01/03/2023]
Abstract
The transferability of a Mediterranean diet (MedDiet) in non-Mediterranean populations is appealing. However, little is known about the perceived enablers or barriers toward adherence, particularly in Australia. This study aimed to investigate the perceived beliefs, barriers, and enablers toward adherence to a MedDiet in Australian adults. Barriers and enablers were assessed using a self-administered online questionnaire, which included questions aligned with the Theory of Planned Behaviour (TPB). The survey was completed by n = 606 participants. Barriers and enablers toward adherence to MedDiet were grouped under the three core constructs of the TPB: attitudes (suitability, taste, restrictive, food waste); social norms (food culture); and perceived behavioural control (PBC) (motivation, affordability, time/effort, food access, knowledge, food outlets, natural conditions, cooking skills). PBC emerged as the most prominent construct influencing intention to follow a MedDiet. Perceived health benefits (n = 445; 76.5%) and improved diet quality (n = 224; 38.5%) were identified as major advantages. In contrast, dietary adherence (n = 147; 39.7%) was perceived as an important disadvantage. Future MedDiet interventions, in both research and clinical settings, should consider adopting strategies aimed at improving self-efficacy to reduce self-perceived barriers and facilitate dietary adherence.
Collapse
|
16
|
Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study. Metabolites 2020; 10:metabo10100392. [PMID: 33023123 PMCID: PMC7601817 DOI: 10.3390/metabo10100392] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2020] [Revised: 09/24/2020] [Accepted: 09/30/2020] [Indexed: 12/31/2022] Open
Abstract
Extra virgin olive oil (EVOO) intake is associated with reduced cardiovascular risk, and its phenolic compound oleocanthal (OC) has anti-oxidant and anti-inflammatory properties. The cardiometabolic effects of EVOO with a high OC concentration have not been fully elucidated. We administered EVOO with a high OC concentration daily to 23 subjects with the metabolic syndrome (MetS) and hepatic steatosis (15 men and 8 women, age: 60 ± 11 years) for 2 months. Anthropometric data, metabolic parameters, hepatic steatosis (by fatty liver index, FLI), abdominal fat distribution (by ultrasound), and pro- and anti-inflammatory cytokines were assessed before and after the intervention. EVOO supplementation was associated with a reduction in body weight, waist circumference, body mass index (BMI), alanine transaminase and FLI, as well as interleukin (IL)-6, IL-17A, tumor necrosis factor-α and IL-1B, while IL-10 increased. Maximum subcutaneous fat thickness (SFT max) also increased, with a concomitant decrease in the ratio of visceral fat layer thickness/SFT max. Correlation analysis revealed positive associations between changes in body weight and BMI and those in SFT max, along with an inverse association between changes in IL-6 and those in SFT max. In conclusion, ingestion of EVOO with a high OC concentration had beneficial effects on metabolic parameters, inflammatory cytokines and abdominal fat distribution in MetS subjects with hepatic steatosis, a category of patients at high cardiometabolic risk.
Collapse
|
17
|
Bouzas C, Bibiloni MDM, Julibert A, Ruiz-Canela M, Salas-Salvadó J, Corella D, Zomeño MD, Romaguera D, Vioque J, Alonso-Gómez ÁM, Wärnberg J, Martínez JA, Serra-Majem L, Estruch R, Tinahones FJ, Lapetra J, Pintó X, García Ríos A, Bueno-Cavanillas A, Gaforio JJ, Matía-Martín P, Daimiel L, Martín-Sánchez V, Vidal J, Vázquez C, Ros E, Fernandez-Lázaro CI, Becerra-Tomás N, Gimenez-Alba IM, Muñoz J, Morey M, Oncina-Canovas A, Tojal-Sierra L, Pérez-López J, Abete I, Casañas-Quintana T, Castro-Barquero S, Bernal-López MR, Santos-Lozano JM, Galera A, Angullo-Martinez E, Basterra-Gortari FJ, Basora J, Saiz C, Castañer O, Martín M, Notario-Barandiarán L, Belló-Mora MC, Sayón-Orea C, García-Gavilán J, Goday A, Tur JA. Adherence to the Mediterranean Lifestyle and Desired Body Weight Loss in a Mediterranean Adult Population with Overweight: A PREDIMED-Plus Study. Nutrients 2020; 12:nu12072114. [PMID: 32708828 PMCID: PMC7400596 DOI: 10.3390/nu12072114] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2020] [Revised: 07/03/2020] [Accepted: 07/09/2020] [Indexed: 01/02/2023] Open
Abstract
Background. Body weight dissatisfaction is a hindrance to following a healthy lifestyle and it has been associated with weight concerns. Objectives. The aim of this study was to assess the association between the adherence to the Mediterranean lifestyle (diet and exercise) and the desired body weight loss in an adult Mediterranean population with overweight. Methods. Cross-sectional analysis in 6355 participants (3268 men; 3087 women) with metabolic syndrome and BMI (Body mass index) between 27.0 and 40.0 kg/m2 (55–75 years old) from the PREDIMED-Plus trial. Desired weight loss was the percentage of weight that participants wished to lose. It was categorized into four cut-offs of this percentage (Q1: <10%, n = 1495; Q2: 10–15%, n = 1804; Q3: <15–20%, n = 1470; Q4: ≥20%, n = 1589). Diet was assessed using a validated food frequency questionnaire and a 17-item Mediterranean diet questionnaire. Physical activity was assessed by the validated Minnesota-REGICOR and the validated Spanish version of the Nurses’ Health Study questionnaire. Results. Participants reporting higher percentages of desired weight loss (Q3 and Q4) were younger, had higher real and perceived BMI and were more likely to have abdominal obesity. Desired weight loss correlated inversely to physical activity (Q1: 2106 MET min/week; Q4: 1585 MET min/week. p < 0.001) and adherence to Mediterranean diet (Q1: 8.7; Q4: 8.3. p < 0.001). Conclusions. In older Mediterranean individuals with weight excess, desired weight loss was inversely associated with Mediterranean lifestyle adherence. Deeply rooted aspects of the MedDiet remained similar across groups. Longitudinal research is advised to be able to establish causality.
Collapse
Affiliation(s)
- Cristina Bouzas
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Guillem Colom Bldg, Campus, 07122 Palma de Mallorca, Spain;
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Maria del Mar Bibiloni
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Guillem Colom Bldg, Campus, 07122 Palma de Mallorca, Spain;
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Alicia Julibert
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Guillem Colom Bldg, Campus, 07122 Palma de Mallorca, Spain;
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Miguel Ruiz-Canela
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Preventive Medicine and Public Health, IdISNA, University of Navarra, 31008 Pamplona, Spain
| | - Jordi Salas-Salvadó
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Universitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Human Nutrition Unit, 43201 Reus, Spain
- Institut d’Investigació Sanitària Pere Virgili (IISPV), 43201 Reus, Spain
| | - Dolores Corella
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Preventive Medicine, University of Valencia, 46100 Valencia, Spain
| | - Maria Dolors Zomeño
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d’Investigació Mèdica (IMIM), 08003 Barcelona, Spain
- Blanquerna School of Health Sciences, Universitat Ramon Llull, 08022 Barcelona, Spain
| | - Dora Romaguera
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Jesús Vioque
- Unit of Nutritional Epidemiology, Miguel Hernández University, ISABIAL-UMH, 46020 Alicante, Spain; (J.V.); (A.O.-C.); (L.N.-B.)
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (A.B.-C.); (J.J.G.)
| | - Ángel M. Alonso-Gómez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Bioaraba Health Research Institute; Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, 48013 Vitoria-Gasteiz, Spain
| | - Julia Wärnberg
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, 29071 Málaga, Spain
| | - J. Alfredo Martínez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Precision Nutrition Program, IMDEA Food, CEI UAM + CSIC, 28049 Madrid, Spain
- Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, 31008 Pamplona, Spain
| | - Luís Serra-Majem
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Institute for Biomedical Research, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain
| | - Ramon Estruch
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain
| | - Francisco J. Tinahones
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Virgen de la Victoria Hospital, Department of Endocrinology, Biomedical Research Institute of Málaga (IBIMA), University of Málaga, 29010 Málaga, Spain
| | - José Lapetra
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, 41013 Sevilla, Spain
| | - Xavier Pintó
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Antonio García Ríos
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, 14004 Cordoba, Spain
| | - Aurora Bueno-Cavanillas
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (A.B.-C.); (J.J.G.)
- Department of Preventive Medicine, University of Granada, 18071 Granada, Spain
| | - José J. Gaforio
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (A.B.-C.); (J.J.G.)
- Department of Health Sciences, Centro de Estudios Avanzados en Olivar y Aceites de Oliva, University of Jaen, 23071 Jaen, Spain
| | - Pilar Matía-Martín
- Department of Endocrinology and Nutrition, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain;
| | - Lidia Daimiel
- Nutritional Genomics and Epigenomics Group, IMDEA Food, CEI UAM + CSIC, 28049 Madrid, Spain;
| | - Vicente Martín-Sánchez
- CIBER Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain;
- Institute of Biomedicine (IBIOMED), University of León, 24071 León, Spain
| | - Josep Vidal
- Department of Endocrinology, IDIBAPS, Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain;
| | - Clotilde Vázquez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Endocrinology, Fundación Jiménez-Díaz, 28040 Madrid, Spain
| | - Emilio Ros
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Lipid Clinic, Department of Endocrinology and Nutrition, Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain
| | - Cesar Ignacio Fernandez-Lázaro
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Preventive Medicine and Public Health, IdISNA, University of Navarra, 31008 Pamplona, Spain
| | - Nerea Becerra-Tomás
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Universitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Human Nutrition Unit, 43201 Reus, Spain
| | - Ignacio Manuel Gimenez-Alba
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Preventive Medicine, University of Valencia, 46100 Valencia, Spain
| | - Julia Muñoz
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d’Investigació Mèdica (IMIM), 08003 Barcelona, Spain
| | - Marga Morey
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Alejandro Oncina-Canovas
- Unit of Nutritional Epidemiology, Miguel Hernández University, ISABIAL-UMH, 46020 Alicante, Spain; (J.V.); (A.O.-C.); (L.N.-B.)
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (A.B.-C.); (J.J.G.)
| | - Lucas Tojal-Sierra
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Guillem Colom Bldg, Campus, 07122 Palma de Mallorca, Spain;
- Bioaraba Health Research Institute; Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, 48013 Vitoria-Gasteiz, Spain
| | - Jéssica Pérez-López
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, 29071 Málaga, Spain
| | - Itziar Abete
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, 31008 Pamplona, Spain
| | - Tamara Casañas-Quintana
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Institute for Biomedical Research, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain
| | - Sara Castro-Barquero
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain
| | - M. Rosa Bernal-López
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Virgen de la Victoria Hospital, Department of Endocrinology, Biomedical Research Institute of Málaga (IBIMA), University of Málaga, 29010 Málaga, Spain
| | - José Manuel Santos-Lozano
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, 41013 Sevilla, Spain
| | - Ana Galera
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Escarlata Angullo-Martinez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Guillem Colom Bldg, Campus, 07122 Palma de Mallorca, Spain;
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
- Escola Graduada Primary Health Care Center, IBSalut, 07002 Palma de Mallorca, Spain
| | - F. Javier Basterra-Gortari
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Preventive Medicine and Public Health, IdISNA, University of Navarra, 31008 Pamplona, Spain
- Servicio Navarro de Salud, Osasunbidea, 31071 Pamplona, Spain
| | - Josep Basora
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Universitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Human Nutrition Unit, 43201 Reus, Spain
| | - Carmen Saiz
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Preventive Medicine, University of Valencia, 46100 Valencia, Spain
| | - Olga Castañer
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d’Investigació Mèdica (IMIM), 08003 Barcelona, Spain
| | - Marian Martín
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Leyre Notario-Barandiarán
- Unit of Nutritional Epidemiology, Miguel Hernández University, ISABIAL-UMH, 46020 Alicante, Spain; (J.V.); (A.O.-C.); (L.N.-B.)
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (A.B.-C.); (J.J.G.)
| | - María C. Belló-Mora
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Bioaraba Health Research Institute; Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, 48013 Vitoria-Gasteiz, Spain
| | - Carmen Sayón-Orea
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Department of Preventive Medicine and Public Health, IdISNA, University of Navarra, 31008 Pamplona, Spain
- Servicio Navarro de Salud, Osasunbidea, 31071 Pamplona, Spain
| | - Jesús García-Gavilán
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Universitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Human Nutrition Unit, 43201 Reus, Spain
| | - Albert Goday
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d’Investigació Mèdica (IMIM), 08003 Barcelona, Spain
| | - Josep A. Tur
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (C.B.); (M.d.M.B.); (A.J.); (M.R.-C.); (J.S.-S.); (D.C.); (M.D.Z.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (F.J.T.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (J.M.); (M.M.); (J.P.-L.); (I.A.); (T.C.-Q.); (S.C.-B.); (M.R.B.-L.); (J.M.S.-L.); (A.G.); (E.A.-M.); (F.J.B.-G.); (J.B.); (C.S.); (O.C.); (M.M.); (M.C.B.-M.); (C.S.-O.); (J.G.-G.); (A.G.)
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Guillem Colom Bldg, Campus, 07122 Palma de Mallorca, Spain;
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
- Correspondence: ; Tel.: +34-971-1731; Fax: +34-971-173184
| |
Collapse
|
18
|
Translation of a Mediterranean-Style Diet into the Australian Dietary Guidelines: A Nutritional, Ecological and Environmental Perspective. Nutrients 2019; 11:nu11102507. [PMID: 31635208 PMCID: PMC6835345 DOI: 10.3390/nu11102507] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2019] [Revised: 10/07/2019] [Accepted: 10/15/2019] [Indexed: 12/13/2022] Open
Abstract
A Mediterranean diet (MedDiet) has been widely investigated and promoted as one of the 'healthiest' dietary patterns with respect to reductions in chronic disease risk and longevity. Moreover, it also emphasizes a plant-based dietary pattern consistent with an environmentally sustainable healthy reference diet conveyed by the EAT-Lancet Commission report. Nevertheless, the MedDiet does not exclude, but rather moderates consumption of animal-based foods, and therefore has emerged as a dietary pattern that could address both health and environmental concerns. However, whether non-Mediterranean countries such as Australia can adhere to such dietary principles is less clear. In this narrative review, we present evidence from eight randomized control trials conducted in Australia which demonstrates impressive and sustained adherence to a MedDiet intervention. However, we also report heterogeneity in the dietary protocols and prescriptive interpretation of a MedDiet across all studies presented in this review, making interpretations of the efficacy and adherence challenging. Based on the observable health benefits, translating key dietary elements of a Mediterranean-style diet within the Australian population remains attractive. However, adapting or modernizing traditional dietary patterns to satisfy the population's nutritional requirements and/or acceptability warrants further exploration.
Collapse
|
19
|
de Carvalho GB, Dias-Vasconcelos NL, Santos RKF, Brandão-Lima PN, da Silva DG, Pires LV. Effect of different dietary patterns on glycemic control in individuals with type 2 diabetes mellitus: A systematic review. Crit Rev Food Sci Nutr 2019; 60:1999-2010. [PMID: 31204492 DOI: 10.1080/10408398.2019.1624498] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Different dietary patterns have been positively related to the glycemic control of individuals with type 2 diabetes mellitus. However, consensual dietary pattern for these individuals is not established. We aimed to evaluate the effects of adopting different dietary patterns on glycemic control markers of individuals with type 2 diabetes mellitus. PubMed, Scopus, MEDLINE, Lilacs, Open Thesis and Google Scholar databases were searched using the Medical Subject Headings and terms related to dietary pattern and glycemic control in individuals with type 2 diabetes mellitus. Interventional studies with adults of this population without diabetes-related complications, presenting data on percentage of glycated hemoglobin, and dietary patterns were included. In vitro, animal, reviews, observational, and studies with children, adolescents, pregnant and breastfeeding women were excluded. The time of adoption dietary patterns ranged from eight weeks to four years in randomized clinical trials, and six months in the cohort study. Vegetarian, vegan, Mediterranean, and Dietary Approaches to Stop Hypertension dietary patterns reduced 0.8% on average of percentage of glycated hemoglobin, considering all included studies. It was also observed reduction in fasting glycemia and improvement in Homeostasis Model Assessment of Insulin Sensitivity. However, more randomized clinical trials are required for a full elucidation of these questions.
Collapse
Affiliation(s)
| | | | | | | | - Danielle Góes da Silva
- Postgraduate Program in Nutrition Sciences, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
- Department of Nutrition, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
| | - Liliane Viana Pires
- Postgraduate Program in Nutrition Sciences, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
- Department of Nutrition, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil
| |
Collapse
|
20
|
Godos J, Ferri R, Caraci F, Cosentino FII, Castellano S, Galvano F, Grosso G. Adherence to the Mediterranean Diet is Associated with Better Sleep Quality in Italian Adults. Nutrients 2019; 11:E976. [PMID: 31035395 PMCID: PMC6566275 DOI: 10.3390/nu11050976] [Citation(s) in RCA: 62] [Impact Index Per Article: 12.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2019] [Revised: 04/24/2019] [Accepted: 04/25/2019] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND Sleep quality has been associated with human health and diseases, including cognitive decline and dementia; however major determinants of sleep disorders are largely unknown. The aim of this study was to evaluate the association between sleep quality and adherence to the Mediterranean dietary pattern in a sample of Italian adults. METHODS A total of 1936 individuals were recruited in the urban area of Catania during 2014-2015 through random sampling. A food frequency questionnaire and validated instruments were used to assess the adherence to the Mediterranean diet and sleep quality (Pittsburg sleep quality index). Multivariate logistic regressions were performed to determine the association between exposure and outcome. RESULTS A total of 1314 individuals (67.9% of the cohort) reported adequate sleep quality: for each point increase of the Mediterranean diet score, individuals were 10% more likely to have adequate sleep quality. In an additional analysis stratifying the sample by weight status, the association between sleep quality and high adherence to the Mediterranean diet was observed only among normal/overweight individuals but not in obese participants. CONCLUSIONS high adherence to a Mediterranean diet is associated with better sleep quality either toward direct effect on health or indirect effects through improvement of weight status.
Collapse
Affiliation(s)
- Justyna Godos
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
| | | | - Filippo Caraci
- Oasi Research Institute - IRCCS, 94018 Troina, Italy.
- Department of Drug Sciences, University of Catania, 95125 Catania, Italy.
| | | | - Sabrina Castellano
- Department of Educational Sciences, University of Catania, 95124 Catania, Italy.
| | - Fabio Galvano
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
| | - Giuseppe Grosso
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
| |
Collapse
|